Max Planck Society

Max Planck- Gesselschaft is one of 80 Max Planck Institutes for the study and advancement of science. The Max Planck Society was established in 1948 and is headquartered in Munich, Germany with outreach around the globe. Max Planck was the founder of quantum theory. Today the Max Planck Institutes are respected around the globe for preeminent research which resulted in its associates being awarded 17 Nobel Prizes. Research is divided into two sections; -The Biology and Medicine Section and the Chemistry, Physics and Technology Section with approximately 7 sub-topics areas of research. The Max Planck institutes supports over 4100 scientists, 10,000 doctoral students and scholars. Its annual budget is approximately 1.3 billion Euros. The institutes are formed as not for profit and their influence is appreciated in scientific institutions around the globe.

Address
P.O. Box 10 10 62 80084 Munchen
Website
http://www.mpg.de/english/portal/index.html
Wikipedia
http://en.wikipedia.org/wiki/Max_Planck_Society

Some content from Wikipedia, licensed under CC BY-SA

Subscribe to rss feed

Immunology

Studies in African killifish reveal how the immune system ages

As we age, our immune system works less well. We become more susceptible to infections and vaccinations no longer work as effectively. A research team led by Dario Riccardo Valenzano investigated whether short-lived killifish ...

Diseases, Conditions, Syndromes

Booster for immune protection after COVID infection

When our immune system comes into contact with the SARS-CoV-2 coronavirus, it fights back and produces antibodies. A similar immune response is triggered by coronavirus vaccines. However, there is still little data available ...

Neuroscience

Brain stress factor regulates obesity

For the first time, the Max Planck Institute of Psychiatry and the University Hospital Bonn have been able to directly link a stress factor in the brain to the cell's recycling system and obesity. This could enable a completely ...

Oncology & Cancer

Proteogenomics identifies novel acute myeloid leukemia subtypes

In order to better treat patients diagnosed with acute myeloid leukemia (AML), the pathological processes and also existing subtypes of the disease must be better understood. With the help of proteome and genome analysis, ...

page 1 from 40